0
0.5
1
1.5
2+
Hospitalization
67%
Improvement
Relative Risk
Progression
19%
Progression (b)
6%
primary
Aspirin ACTIV-4B EARLY TREATMENT DB RCT
Is early treatment with aspirin beneficial for COVID-19?
Double-blind RCT 280 patients in the USA (September 2020 - June 2021)
Lower hospitalization with aspirin (not stat. sig., p=0.49)
c19early.org
Connors et al., JAMA, October 2021
Favors aspirin
Favors control